RA CAPITAL MANAGEMENT, LLC
Q4 2013 13F-HR Holdings
Net value change ($000)
—
New positions
24
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ACHILLION PHARMACEUTICALS INC | 77,552 | — |
| SGMO | 72,607 | — |
| TXMD | 60,749 | — |
| NVAX | 55,357 | — |
| OPHTHOTECH CORP | 51,775 | — |
| PRTA | 43,524 | — |
| *DYNAVAX TECHNOLOGIES CORP | 35,053 | — |
| BCRX | 33,041 | — |
| ACAD | 29,236 | — |
| XNCR | 24,907 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
210,668
(24.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|